RFS
ACAD icon

Rockefeller Financial Services’s Acadia Pharmaceuticals ACAD Stock Holding History

Rockefeller Financial Services’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-5,695
Closed -$239K – 511
2015
Q2 		$239K Sell
5,695
-508
-8% -$19.7K 0.01% 299
2015
Q1 		$202K Hold
6,203
– – ﹤0.01% 320
2014
Q4 		$197K Sell
6,203
-548
-8% -$15.5K ﹤0.01% 305
2014
Q3 		$167K Sell
6,751
-7,541
-53% -$176K ﹤0.01% 336
2014
Q2 		$323K Buy
14,292
+4,706
+49% +$98.3K 0.01% 303
2014
Q1 		$233K Buy
+9,586
New +$242K 0.01% 329

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Rockefeller Financial Services's ACAD Position: Q3 2015 in Review

Rockefeller Financial Services sold out of Acadia Pharmaceuticals (ACAD) in Q3 2015, closing a stake of 5,695 shares — an estimated $239K sold.

Rockefeller Financial Services first reported a position in ACAD in Q1 2014 and held it in 6 quarters. The position peaked at $323K in Q2 2014. 188 funds tracked by Wall St. Rank hold ACAD as of Q3 2015.

  • Rockefeller Financial Services reported no remaining Acadia Pharmaceuticals position as of Q3 2015 after selling out during the quarter.
  • Rockefeller Financial Services sold 5,695 Acadia Pharmaceuticals shares in Q3 2015, an estimated $239K.
  • Rockefeller Financial Services first reported a position in Acadia Pharmaceuticals in Q1 2014 and held it in 6 quarters.
  • Rockefeller Financial Services's Acadia Pharmaceuticals position peaked at $323K in Q2 2014.
  • 188 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q3 2015.

Based on Rockefeller Financial Services's 13F filing for Q3 2015, filed 23 Oct 2015.